First Time Loading...
M

Medtech Acquisition Corp
NASDAQ:MTAC

Watchlist Manager
Medtech Acquisition Corp
NASDAQ:MTAC
Watchlist
Price: 11.34 USD 18.62% Market Closed
Updated: Apr 26, 2024

Intrinsic Value

MedTech Acquisition Corp. is a blank check company, whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combinat... [ Read More ]

There is not enough data to reliably calculate the intrinsic value of MTAC.

Key Points:
MTAC Intrinsic Value
Base Case
Not Available
M
Base Case Scenario

Fundamental Analysis

Beta
Ask me anything about
Medtech Acquisition Corp

Provide an overview of the primary business activities
of Medtech Acquisition Corp.

What unique competitive advantages
does Medtech Acquisition Corp hold over its rivals?

What risks and challenges
does Medtech Acquisition Corp face in the near future?

Show all valuation multiples
for Medtech Acquisition Corp.

Provide P/S
for Medtech Acquisition Corp.

Provide P/E
for Medtech Acquisition Corp.

Provide P/OCF
for Medtech Acquisition Corp.

Provide P/FCFE
for Medtech Acquisition Corp.

Provide P/B
for Medtech Acquisition Corp.

Provide EV/S
for Medtech Acquisition Corp.

Provide EV/GP
for Medtech Acquisition Corp.

Provide EV/EBITDA
for Medtech Acquisition Corp.

Provide EV/EBIT
for Medtech Acquisition Corp.

Provide EV/OCF
for Medtech Acquisition Corp.

Provide EV/FCFF
for Medtech Acquisition Corp.

Provide EV/IC
for Medtech Acquisition Corp.

Compare the intrinsic valuations
of Medtech Acquisition Corp and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Medtech Acquisition Corp against its competitors.

Analyze the profit margins
(gross, operating, and net) of Medtech Acquisition Corp compared to its peers.

Compare the P/E ratios
of Medtech Acquisition Corp against its peers.

Discuss the investment returns and shareholder value creation
comparing Medtech Acquisition Corp with its peers.

Analyze the financial leverage
of Medtech Acquisition Corp compared to its main competitors.

Show all profitability ratios
for Medtech Acquisition Corp.

Provide ROE
for Medtech Acquisition Corp.

Provide ROA
for Medtech Acquisition Corp.

Provide ROIC
for Medtech Acquisition Corp.

Provide ROCE
for Medtech Acquisition Corp.

Provide Gross Margin
for Medtech Acquisition Corp.

Provide Operating Margin
for Medtech Acquisition Corp.

Provide Net Margin
for Medtech Acquisition Corp.

Provide FCF Margin
for Medtech Acquisition Corp.

Show all solvency ratios
for Medtech Acquisition Corp.

Provide D/E Ratio
for Medtech Acquisition Corp.

Provide D/A Ratio
for Medtech Acquisition Corp.

Provide Interest Coverage Ratio
for Medtech Acquisition Corp.

Provide Altman Z-Score Ratio
for Medtech Acquisition Corp.

Provide Quick Ratio
for Medtech Acquisition Corp.

Provide Current Ratio
for Medtech Acquisition Corp.

Provide Cash Ratio
for Medtech Acquisition Corp.

What is the historical Revenue growth
over the last 5 years for Medtech Acquisition Corp?

What is the historical Net Income growth
over the last 5 years for Medtech Acquisition Corp?

What is the current Free Cash Flow
of Medtech Acquisition Corp?

Discuss the annual earnings per share (EPS)
trend over the past five years for Medtech Acquisition Corp.

Financials

Balance Sheet Decomposition
Medtech Acquisition Corp

Current Assets 300.9k
Cash & Short-Term Investments 136.8k
Other Current Assets 164.1k
Non-Current Assets 20.2m
Other Non-Current Assets 20.2m
Current Liabilities 4.7m
Accounts Payable 1.6m
Other Current Liabilities 3.1m
Non-Current Liabilities 9.5m
Other Non-Current Liabilities 9.5m
Efficiency

Earnings Waterfall
Medtech Acquisition Corp

Revenue
0 USD
Operating Expenses
-2.9m USD
Operating Income
-2.9m USD
Other Expenses
5.2m USD
Net Income
2.3m USD

Free Cash Flow Analysis
Medtech Acquisition Corp

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

MTAC Profitability Score
Profitability Due Diligence

Medtech Acquisition Corp's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

Negative Free Cash Flow
Low ROE
Negative ROIC
Negative Operating Income
41/100
Profitability
Score

Medtech Acquisition Corp's profitability score is 41/100. The higher the profitability score, the more profitable the company is.

MTAC Solvency Score
Solvency Due Diligence

Medtech Acquisition Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Low D/E
Long-Term Solvency
Average Altman Z-Score
Short-Term Solvency
49/100
Solvency
Score

Medtech Acquisition Corp's solvency score is 49/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

MTAC Price Targets Summary
Medtech Acquisition Corp

There are no price targets for MTAC.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

MTAC Price
Medtech Acquisition Corp

1M 1M
-
6M 6M
-
1Y 1Y
+10%
3Y 3Y
+17%
5Y 5Y
+8%
10Y 10Y
+8%
Annual Price Range
11.34
52w Low
9.34
52w High
11.34
Price Metrics
Average Annual Return -5.42%
Standard Deviation of Annual Returns
N/A
Max Drawdown -14%
Shares Statistics
Market Capitalization 93m USD
Shares Outstanding 8 203 422
Percentage of Shares Shorted 0.06%

MTAC Return Decomposition
Main factors of price return

What is price return decomposition?

Company Profile

Medtech Acquisition Corp

Country

United States of America

Industry

N/A

Market Cap

93m USD

Dividend Yield

0%

Description

MedTech Acquisition Corp. is a blank check company, whose business purpose is to effect a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The company is headquartered in Greenwich, Connecticut. The company went IPO on 2020-12-18. The firm is formed for the purpose of effecting a merger, capital stock exchange, asset acquisition, stock purchase, reorganization or similar business combination with one or more businesses. The firm intends to focus on businesses primarily operating in the healthcare sector in the United States. The firm has not commenced any business operations and has not generated any revenue.

Contact

CONNECTICUT
Greenwich
48 Maple Avenue, 22nd Floor
+19083911288.0

IPO

2020-12-18

Employees

-

Officers

CEO & Director
Mr. Christopher C. Dewey
CFO & Director
Mr. David J. Matlin J.D.
Chief Admin. Officer & Sec.
Mr. Robert H. Weiss J.D.

See Also

Discover More